• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday

    8/10/23 7:53:21 AM ET
    $ARHS
    $DBTX
    $DCPH
    $FLT
    Other Specialty Stores
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ARHS alert in real time by email
    • Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ:IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on Wednesday.
    • Telsey Advisory Group increased Arhaus, Inc. (NASDAQ:ARHS) price target from $13 to $15. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Arhaus shares gained 8.7% to close at $12.61 on Wednesday.
    • Piper Sandler boosted the price target for Wix.com Ltd. (NASDAQ:WIX) from $120 to $130. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Wix.com shares fell 0.7% to close at $90.41 on Wednesday.
    • Raymond James increased the price target for FLEETCOR Technologies, Inc. (NYSE:FLT) from $246 to $283. Raymond James analyst John Davis maintained an Outperform rating. FLEETCOR Technologies shares gained 6.3% to close at $260.04 on Wednesday.
    • Needham cut Viridian Therapeutics, Inc. (NASDAQ:VRDN) price target from $47 to $40. Needham analyst Serge Belanger maintained a Buy rating. Viridian Therapeutics shares rose 2.7% to close at $19.26 on Wednesday.
    • HC Wainwright & Co. slashed Terns Pharmaceuticals, Inc. (NASDAQ:TERN) price target from $11 to $8. HC Wainwright & Co. analyst Ed Arce maintained a Neutral rating. Terns Pharmaceuticals shares fell 13.7% to close at $6.03 on Wednesday.
    • Stifel increased Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) price target from $14 to $20. Stifel analyst Bradley Canino upgraded the stock from Hold to Buy. Deciphera Pharmaceuticals shares gained 6.2% to close at $13.74 on Wednesday.
    • Jefferies boosted Global Payments Inc. (NYSE:GPN) price target from $125 to $145. Jefferies analyst Trevor Williams upgraded the stock from Hold to Buy. Global Payments shares fell 0.3% to close at $124.04 on Wednesday.
    • DA Davidson slashed the price target for OneSpan Inc. (NASDAQ:OSPN) from $19 to $12. DA Davidson analyst Andrew Nowinski downgraded the stock from Buy to Neutral. OneSpan shares fell 4.1% to $12.79 in pre-market trading.
    • Goldman Sachs lowered Nuvei Corporation (NASDAQ:NVEI) price target from $41 to $22. Goldman Sachs analyst Will Nance downgraded the stock from Buy to Neutral. Nuvei shares fell 0.6% to $18.02 in pre-market trading.
    • Baird cut Decibel Therapeutics, Inc. (NASDAQ:DBTX) price target from $21 to $5.25. Baird analyst Jack Allen downgraded the stock from Outperform to Neutral. Decibel Therapeutics shares fell 1.6% to $4.95 in pre-market trading.

     

    Check This Out: Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday

    Get the next $ARHS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARHS
    $DBTX
    $DCPH
    $FLT

    CompanyDatePrice TargetRatingAnalyst
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Global Payments Inc.
    $GPN
    1/27/2026$80.00Neutral
    Cantor Fitzgerald
    Global Payments Inc.
    $GPN
    1/14/2026$80.00Hold
    Deutsche Bank
    Global Payments Inc.
    $GPN
    1/14/2026$109.00Neutral → Buy
    Seaport Research Partners
    Viridian Therapeutics Inc.
    $VRDN
    12/10/2025$42.00 → $47.00Outperform
    Wedbush
    Viridian Therapeutics Inc.
    $VRDN
    12/3/2025Outperform
    William Blair
    Viridian Therapeutics Inc.
    $VRDN
    11/24/2025Buy
    Truist
    Wix.com Ltd.
    $WIX
    11/20/2025$200.00 → $140.00Buy
    Needham
    More analyst ratings

    $ARHS
    $DBTX
    $DCPH
    $FLT
    SEC Filings

    View All

    SEC Form 10-K filed by Global Payments Inc.

    10-K - GLOBAL PAYMENTS INC (0001123360) (Filer)

    2/20/26 4:05:09 PM ET
    $GPN
    Real Estate

    SEC Form 144 filed by Global Payments Inc.

    144 - GLOBAL PAYMENTS INC (0001123360) (Subject)

    2/19/26 1:44:47 PM ET
    $GPN
    Real Estate

    Global Payments Inc. filed SEC Form 8-K: Other Events

    8-K - GLOBAL PAYMENTS INC (0001123360) (Filer)

    2/19/26 8:30:03 AM ET
    $GPN
    Real Estate

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arhaus to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    BOSTON HEIGHTS, Ohio, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omnichannel retailer of premium artisan-crafted home furnishings, will release its fourth quarter and full year 2025 results on Thursday, February 26, 2026, before the stock market opens, followed by a conference call to review the Company's financial and operational results at 8:30 a.m. Eastern Time. A live webcast will be available at ir.arhaus.com. To participate in the live call, dial:U.S. Toll-Free: (877) 407-3982International: 1 (201) 493-6780Conference ID: 13748994 A telephone replay will be available for one week at:U.S. Toll-Free: 1-844-5

    2/19/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Global Payments Announces Board Appointment

    Global Payments Inc. (NYSE:GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced the appointment of Vivek Sankaran as a new independent director to the company's Board of Directors, effective February 19, 2026. "Vivek is a terrific addition to our board of directors," said Troy Woods, chair of the Global Payments Board of Directors. "His deep expertise leading technology and digital transformations, as well as his extensive executive experience at some of the most recognizable global brands, will be an invaluable addition to the leadership of this company." "I am delighted to extend a warm welcome to Vivek, an

    2/18/26 7:00:00 AM ET
    $GPN
    Real Estate

    Global Payments Reports Fourth Quarter and Full Year 2025 Results

    Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.921 and adjusted EPS of $3.18, an increase of 11% constant currency Fourth quarter 2025 GAAP revenue of $1.90 billion1 and adjusted net revenue of $2.32 billion, an increase of 6% constant currency ex-dispositions Completed acquisition of Worldpay and divestiture of Issuer Solutions, repositioning the company as a leading pure-play merchant solutions provider Announces share repurchase authorization of $2.5 billion Entering into $550 million accelerated share repurchase plan Provides 2026 outlook for the new Global Payments Global Payments Inc. (NYSE:GPN) today announced results for the fourth quarter and yea

    2/18/26 6:55:00 AM ET
    $GPN
    Real Estate

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by General Counsel Mataac Lara

    4 - OneSpan Inc. (0001044777) (Issuer)

    2/20/26 5:16:41 PM ET
    $OSPN
    EDP Services
    Technology

    SEC Form 4 filed by Chief Financial Officer Martell Jorge Garcia

    4 - OneSpan Inc. (0001044777) (Issuer)

    2/20/26 5:12:08 PM ET
    $OSPN
    EDP Services
    Technology

    SEC Form 4 filed by Chief Technology Officer Jain Ashish

    4 - OneSpan Inc. (0001044777) (Issuer)

    2/20/26 5:06:52 PM ET
    $OSPN
    EDP Services
    Technology

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baldwin Robert H B Jr bought $1,086,867 worth of shares (13,392 units at $81.16) and gifted 13,392 shares (SEC Form 4)

    4 - GLOBAL PAYMENTS INC (0001123360) (Issuer)

    12/12/25 8:58:06 AM ET
    $GPN
    Real Estate

    Director Watson Patricia A bought $99,905 worth of shares (1,331 units at $75.06), increasing direct ownership by 101% to 2,651 units (SEC Form 4)

    4 - GLOBAL PAYMENTS INC (0001123360) (Issuer)

    11/10/25 4:27:19 PM ET
    $GPN
    Real Estate

    Director Zenner Marc bought $24,260 worth of shares (2,000 units at $12.13), increasing direct ownership by 3% to 73,273 units (SEC Form 4)

    4 - OneSpan Inc. (0001044777) (Issuer)

    11/5/25 7:51:39 PM ET
    $OSPN
    EDP Services
    Technology

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Leerink Partners initiated coverage on Terns Pharmaceuticals with a new price target

    Leerink Partners initiated coverage of Terns Pharmaceuticals with a rating of Outperform and set a new price target of $58.00

    2/9/26 6:54:14 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on Global Payments with a new price target

    Cantor Fitzgerald initiated coverage of Global Payments with a rating of Neutral and set a new price target of $80.00

    1/27/26 8:46:26 AM ET
    $GPN
    Real Estate

    Deutsche Bank initiated coverage on Global Payments with a new price target

    Deutsche Bank initiated coverage of Global Payments with a rating of Hold and set a new price target of $80.00

    1/14/26 8:40:56 AM ET
    $GPN
    Real Estate

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Leadership Updates

    Live Leadership Updates

    View All

    Global Payments Announces Board Appointment

    Global Payments Inc. (NYSE:GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced the appointment of Vivek Sankaran as a new independent director to the company's Board of Directors, effective February 19, 2026. "Vivek is a terrific addition to our board of directors," said Troy Woods, chair of the Global Payments Board of Directors. "His deep expertise leading technology and digital transformations, as well as his extensive executive experience at some of the most recognizable global brands, will be an invaluable addition to the leadership of this company." "I am delighted to extend a warm welcome to Vivek, an

    2/18/26 7:00:00 AM ET
    $GPN
    Real Estate

    Arhaus Appoints Michael Rengel as Chief Merchandising Officer

    BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026. In this role, Michael will lead Arhaus' merchandising and product strategy across furniture and décor categories, supporting the Company's continued focus on assortment differentiation, product leadership, and disciplined growth. Michael will report to John Reed, Founder and Chief Executive Officer, and will oversee Product Development and Merchandising. Michael brings more tha

    2/12/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    OneSpan Appoints Shaun Bierweiler as Chief Revenue Officer

    Seasoned SaaS and cybersecurity leader to drive global growth and customer success OneSpan Inc. (NASDAQ:OSPN) today announced the appointment of Shaun Bierweiler as Chief Revenue Officer (CRO). In this role, Shaun will lead OneSpan's global revenue organization, including sales, marketing, channels, customer success, and revenue operations, driving growth and operational excellence across the customer lifecycle. A veteran go-to-market leader, Shaun brings over two decades of experience scaling global security, SaaS, networking, and data-driven businesses, as well as building high-performance teams. Most recently, Shaun served as the CRO at Everfox, a global pioneer in defense-grade, high-

    12/2/25 8:00:00 AM ET
    $OSPN
    EDP Services
    Technology

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Financials

    Live finance-specific insights

    View All

    Arhaus to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    BOSTON HEIGHTS, Ohio, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omnichannel retailer of premium artisan-crafted home furnishings, will release its fourth quarter and full year 2025 results on Thursday, February 26, 2026, before the stock market opens, followed by a conference call to review the Company's financial and operational results at 8:30 a.m. Eastern Time. A live webcast will be available at ir.arhaus.com. To participate in the live call, dial:U.S. Toll-Free: (877) 407-3982International: 1 (201) 493-6780Conference ID: 13748994 A telephone replay will be available for one week at:U.S. Toll-Free: 1-844-5

    2/19/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Global Payments Reports Fourth Quarter and Full Year 2025 Results

    Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.921 and adjusted EPS of $3.18, an increase of 11% constant currency Fourth quarter 2025 GAAP revenue of $1.90 billion1 and adjusted net revenue of $2.32 billion, an increase of 6% constant currency ex-dispositions Completed acquisition of Worldpay and divestiture of Issuer Solutions, repositioning the company as a leading pure-play merchant solutions provider Announces share repurchase authorization of $2.5 billion Entering into $550 million accelerated share repurchase plan Provides 2026 outlook for the new Global Payments Global Payments Inc. (NYSE:GPN) today announced results for the fourth quarter and yea

    2/18/26 6:55:00 AM ET
    $GPN
    Real Estate

    Wix to Announce Fourth Quarter and Full Year 2025 Earnings Results on March 4, 2026

    NEW YORK -- Wix.com Ltd. (NASDAQ:WIX), today announced that it will report its results for the fourth quarter and full year ended December 31, 2025 before the market opens on Wednesday, March 4, 2026. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company's financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/.  What:Wix Fourth Quarter and Full Year 2025 Results Conference CallWhen: Wednesday, March 4, 2026Time:8:30 a.m. ET Registration: https://edge.media-server.com/mmc/p/4zs5pwq2 R

    2/12/26 4:30:00 PM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    $ARHS
    $DBTX
    $DCPH
    $FLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nuvei Corporation Subordinate Voting Shares

    SC 13D/A - Nuvei Corp (0001765159) (Subject)

    11/15/24 4:59:27 PM ET
    $NVEI
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Terns Pharmaceuticals Inc.

    SC 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    11/15/24 10:35:07 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Terns Pharmaceuticals Inc.

    SC 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    11/14/24 7:00:26 PM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care